Shape Pharmaceuticals, Inc. — Form D
Shape Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-10-12. The offering totals $4.5M, of which $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-10-12
- Form: D
- Accession: 0001140361-10-040811
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $4.5M
- Amount sold: $1.0M
- Remaining: $3.5M
- Minimum investment: $400K
- Investors: 1
- Date of first sale: 2010-10-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-148863
Issuer
- Name: Shape Pharmaceuticals, Inc.
- CIK: 0001500398
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA, 02142
- Phone: 617 997 9881
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| James E Bradner | Director | Cambridge, MA |
| Augustine E Lawlor | Director | Cambridge, MA |
| Paul E Marks | Director | Cambridge, MA |
| Douglas E Onsi | Director | Cambridge, MA |
| Douglas E Onsi | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More